Last reviewed · How we verify
NCT06419231
Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated Symptoms
NA trial testing Butyrate Formulation in Gut Health in 143 participants. Completed in 18 June 2025.
23 December 2024
Quick facts
| Lead sponsor | Supplement Formulators, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 143 |
| Start date | 31 October 2023 |
| Primary completion | 23 December 2024 |
| Estimated completion | 18 June 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Butyrate Formulation
- Butyrate + Polyphenol Formulation
- Placebo
Conditions studied
- Gut Health — all drugs for Gut Health →
Sponsor
Supplement Formulators, Inc.
Who can join
Adults 21 to 70, any sex, with Gut Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is the assess the effectiveness and safety of a Butyrate formulation and a Butyrate + Polyphenol formulation on gut health, permeability and associated symptoms
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06419231
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gut Health
Currently open trials in the same condition.
- NCT07421596 — An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System · NA · recruiting
- NCT07423897 — Consumer Health Study Aims to Evaluate the Safety, Tolerability and Impact of ED02 Probiotic Supplement on Gastrointesti · NA · active not recruiting
- NCT07408518 — Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes · NA · active not recruiting
- NCT07371975 — A Study to Evaluate the Effects of a Butyrate-Polyphenol Formulation on Gut Health and Associated Symptoms · NA · recruiting
- NCT07109713 — The Effect Cranberry-Based Products on the Female Microbiome · NA · recruiting
Other Supplement Formulators, Inc. trials
Trials by the same sponsor.
- NCT07371975 — A Study to Evaluate the Effects of a Butyrate-Polyphenol Formulation on Gut Health and Associated Symptoms · NA · recruiting
- NCT05854017 — Effects of a Theanine for Stress Relief Formulation in Individuals Who Report Occasional Moderate High Levels of Stress. · NA · active not recruiting
- NCT05450952 — Evaluate the Effects of a Theanine Formulation on Stress, Burnout, Mood, and Sleep in Individuals Who Report Occasional · NA · terminated
- NCT05170113 — Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulatio · NA · completed
- NCT04819646 — Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation/Discomfort · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06419231 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Supplement Formulators, Inc.
- Last refreshed: 13 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06419231.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing